AllNewsPhotosVideos

Glenmark Pharmaceuticals Ltd

Glenmark pharmaceuticals ltd, Latest News

Glenmark to conduct phase III trials of nasal spray it claims to be effective in treating COVID-19 - Hindi News | Glenmark to conduct phase III trials of nasal spray it claims to be effective in treating COVID-19 | Latest national News at Lokmattimes.com

National :Glenmark to conduct phase III trials of nasal spray it claims to be effective in treating COVID-19

Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray, which it claims to be effective in the treatment of COVID-19. ...

Fitch affirms Glenmark Pharmaceuticals at BB with stable outlook - Hindi News | Fitch affirms Glenmark Pharmaceuticals at BB with stable outlook | Latest business News at Lokmattimes.com

Business :Fitch affirms Glenmark Pharmaceuticals at BB with stable outlook

Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB with a stable outlook. ...

Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib Capsules, 100 mg and 150 mg - Hindi News | Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib Capsules, 100 mg and 150 mg | Latest business News at Lokmattimes.com

Business :Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib Capsules, 100 mg and 150 mg

Glenmark Pharmaceuticals Ltd (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Nintedanib Capsules, 100 mg and 150 mg, the generic version of Ofev®1 Capsules, 100 mg and 150 mg, of Boehringer In ...

Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials - Hindi News | Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials | Latest business News at Lokmattimes.com

Business :Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials

Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials, the generic version of BROVANA®1 Inhalation So ...

Glenmark launches dry powder inhaler Tiogiva in UK - Hindi News | Glenmark launches dry powder inhaler Tiogiva in UK | Latest health News at Lokmattimes.com

Health :Glenmark launches dry powder inhaler Tiogiva in UK

Chennai, June 15 Pharma major Glenmark Pharmaceuticals Ltd on Tuesday said it has launched a bioequivalent version of ... ...

Glenmark releases interim data from PMS Study on Favipiravir (FabiFlu®) - Hindi News | Glenmark releases interim data from PMS Study on Favipiravir (FabiFlu®) | Latest business News at Lokmattimes.com

Business :Glenmark releases interim data from PMS Study on Favipiravir (FabiFlu®)

Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study on Favipiravir in India. ...

Glenmark gets USFDA approval for Theophylline ER tablets - Hindi News | Glenmark gets USFDA approval for Theophylline ER tablets | Latest international News at Lokmattimes.com

International :Glenmark gets USFDA approval for Theophylline ER tablets

Chennai, June 4 Pharma major Glenmark Pharmaceuticals Ltd on Friday said it has received the final approval by ... ...

Glenmark Pharmaceuticals receives ANDA approval for Theophylline Extended-release Tablets, 300 mg and 450 mg - Hindi News | Glenmark Pharmaceuticals receives ANDA approval for Theophylline Extended-release Tablets, 300 mg and 450 mg | Latest business News at Lokmattimes.com

Business :Glenmark Pharmaceuticals receives ANDA approval for Theophylline Extended-release Tablets, 300 mg and 450 mg

Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Theophylline Extended-release Tablets, 300 mg and 450 mg, bioequivalent and therapeutically equivalent to the reference ...